Salta al contenuto principale

Deficienza di fosfoglicerato chinasi 1

Questa pagina è stata archiviata.

Non è stato rivisto di recente e non è aggiornato. I link esterni e i riferimenti potrebbero non funzionare più.

Professionisti Medici

Gli articoli di riferimento professionale sono progettati per essere utilizzati dai professionisti della salute. Sono scritti da medici del Regno Unito e basati su prove di ricerca, linee guida del Regno Unito ed europee. Potresti trovare uno dei nostri articoli sulla salute più utile.

Synonyms: Phosphoglycerokinase deficiency, PGK deficiency, PGK1 deficiency, Haemolytic anaemia with PGK Deficiency,

Phosphoglycerate kinase deficiency is a hereditary metabolic disease. Phosphoglycerate kinase (PGK1) is a ubiquitous glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate generating one molecule of ATP. Its gene lies on the X-chromosome (locus Xq13) and there are related pseudogenes on the X-chromosome and chromosome 19.1

It is a complex enzyme: several subtypes of deficiency have been identified,2 based on the tissues in which the enzyme deficiency occurs and the type of inheritance. Clinically, there are two distinct syndromes:

  • A pure muscle syndrome characterized by recurrent cramps and muscle breakdown in response to intense exercise.3

  • A "muscle plus" syndrome which may feature mental retardation and/or haemolytic anaemia.

Different mutations of the erythrocyte enzyme PGK1 gene have been identified but the reason for the multifarious clinical manifestations of mutations of the same gene remains unknown.4

Epidemiologia

  • It is extremely rare.

  • The gene encoding the erythrocyte enzyme PGK1 is X-linked and PGK is transmitted as an X-linked recessive disorder in nearly 75%. Females are carriers and have a 50% chance of transmitting the gene to an affected son or a carrier daughter. Affected males produce carrier daughters and unaffected sons.

  • It is inherited as an autosomal recessive in about 25%.5

Presentazione

  • Presentation is variable but occurs between infancy and adolescence.

  • Clinical findings include:

    • Muscle pain and weakness

    • Rust-coloured urine after vigorous exercise due to myoglobinuria

  • Other features are rare and highly variable but may include:

    • Nausea after exercise

    • Variable degrees of mental retardation

    • Convulsioni

    • Anemia emolitica

  • Some patients may have a purely myopathic syndrome with progressive proximal muscle weakness and episodes of myoglobinuria, exercise intolerance and easy fatigue.

  • There can be emotional lability, aphasia with impaired ability to comprehend speech or writing and hemiplegia.

  • Female carriers may have haemolytic anaemia.

Diagnosi differenziale

There are a number of enzyme defects that can cause myoglobinuria6 as well as other causes to remember:

  • Biochemical abnormalities (eg ipokaliemia, hypophosphataemia)

  • Miopatie

  • McArdle's disease (Glycogen storage disorder V) and Tarui's disease (Glycogen storage disorder VII)

  • Acetyl-CoA dehydrogenase deficiency and lactate dehydrogenase deficiency

  • Polimiosite e dermatomiosite

  • Ipertermia maligna

  • Sindrome maligna da neurolettici

  • Sindrome da schiacciamento

  • Muscle ischaemia secondary to arterial occlusion or insufficiency

  • Setticemia

  • Drug abuse

Indagini

  • Diagnostic testing is available for the absence of the enzyme phosphoglycerate kinase.

  • There is recurrent myoglobinuria, especially after exercise.

  • Serum CK levels are high or normal.

  • Anaerobic exercise produces no rise in lactate.

  • Gene mutation identification within family groups.

Gestione

Non-Drug

Strenuous exercise should be avoided.

Farmaci

None are of proven value.

Chirurgia

Splenectomy can reduce the haemolytic anaemia and the need for transfusion.7

Complicazioni

Myoglobinuria from prolonged exercise can produce renal damage.

Prognosi

Severity varies but the myopathic syndrome is usually slowly progressive. In one study of a large family, many sufferers died before reaching adulthood.8

Prevenzione

Identification of the gene9 may permit prenatal diagnosis with a view to termination of pregnancy.

Aggiornamenti esclusivi per i professionisti sanitari

Rimani informato con gli ultimi aggiornamenti clinici, approfondimenti professionali e linee guida basate su evidenze. La newsletter Patient Pro seleziona contenuti essenziali per i professionisti sanitari—consegnati direttamente nella tua casella di posta.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

Ulteriori letture e riferimenti

  1. Phosphoglycerate Kinase-1 Deficiency, Online Mendelian Inheritance in Man (OMIM)
  2. Tsujino S, Shanske S, DiMauro S; Molecular genetic heterogeneity of phosphoglycerate kinase (PGK) deficiency. Muscle Nerve. 1995;3:S45-9.
  3. Spiegel R, Gomez EA, Akman HO, et al; Myopathic form of phosphoglycerate kinase (PGK) deficiency: A new case and pathogenic considerations. Neuromuscul Disord. 2009 Jan 19.
  4. Beutler E; PGK deficiency. Br J Haematol. 2007 Jan;136(1):3-11.
  5. Phosphoglycerate Kinase (PGK) 1 Deficiency, Online Mendelian Inheritance in Man (OMIM)
  6. Tonin P, Lewis P, Servidei S, et al; Metabolic causes of myoglobinuria. Ann Neurol. 1990 Feb;27(2):181-5.
  7. Fujii H, Miwa S; Other erythrocyte enzyme deficiencies associated with non-haematological symptoms: phosphoglycerate kinase and phosphofructokinase deficiency. Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):141-8.
  8. Turner G, Fletcher J, Elber J, et al; Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred. Br J Haematol. 1995 Sep;91(1):60-5.
  9. Flanagan JM, Rhodes M, Wilson M, et al; The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Br J Haematol. 2006 Jul;134(2):233-7. Epub 2006 Jun 1.

Informazioni sull'autore

Immagine dell'autore

Dr Chloe Borton, MRCGP

BA, PGCE, MBBS, DFFP, MRCGP

Informazioni sul recensoreVisualizza il profilo completo

Immagine dell'autore

Team di clinici e pazienti

Il team clinico di Patient.info crea e revisiona i nostri contenuti sulla salute per garantire che siano accurati, basati su evidenze e guidati dagli affidabili standard NHS e NICE.

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.

verifica idoneità al vaccino antinfluenzale

Chiedi, condividi, connettiti.

Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

verificatore di sintomi

Non ti senti bene?

Valuta i tuoi sintomi online gratuitamente